Cargando…
Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer
Ephrin type-A receptor 2 (EphA2) is a member of the tyrosine receptor kinases, a family of membrane proteins recognized as potential anticancer targets. EphA2 highly expressed in a variety of human cancers, playing roles in proliferation, migration, and invasion. However, whether and how EphA2 regul...
Autores principales: | Zhao, Ping, Sun, Jian, Huang, Xinwei, Zhang, Xiangwu, Liu, Xin, Liu, Rong, Du, Guangshi, Gan, Wenqiang, Yang, Chuanyu, Tang, Yiyin, Chen, Ceshi, Jiang, Dewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092769/ https://www.ncbi.nlm.nih.gov/pubmed/37063424 http://dx.doi.org/10.7150/ijbs.82567 |
Ejemplares similares
-
DNA damage chemotherapeutic drugs suppress basal-like breast cancer growth by down-regulating the transcription of the FOXO1-KLF5 axis
por: Cui, Qiuxia, et al.
Publicado: (2023) -
Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer
por: Fan, Jia, et al.
Publicado: (2018) -
Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer
por: Kong, Yanjie, et al.
Publicado: (2022) -
Targeting EphA2 in cancer
por: Xiao, Ta, et al.
Publicado: (2020) -
EphA5 and EphA6: regulation of neuronal and spine morphology
por: Das, Gitanjali, et al.
Publicado: (2016)